Drug treatments for covid-19: living systematic review and network meta-analysis

Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial

(2020) Yang Cao et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Ramipril in High Risk Patients with COVID-19

(2020) Ignacio J. Amat-Santos et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

(2020) Ivan Fan-Ngai Hung et al.   LANCET

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

(2020) Yeming Wang et al.   LANCET

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

(2020) Jason D. Goldman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Remdesivir for the Treatment of Covid-19 — Preliminary Report

(2020) John H. Beigel et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

(2020) Bin Cao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

(2020) Wei Tang et al.   BMJ-British Medical Journal

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19

(2020) Caleb P. Skipper et al.   ANNALS OF INTERNAL MEDICINE

Efficacy and safety of interferon β-1a in treatment of severe COVID-19: A randomized clinical trial

(2020) Effat Davoudi-Monfared et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Febuxostat therapy in outpatients with suspected COVID‐19: A clinical trial

(2020) Lotfollah Davoodi et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Evidence-based medicine in times of crisis

(2020) Benjamin Djulbegovic et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

(2020) Alexandre B. Cavalcanti et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

(2020) David R. Boulware et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

(2020)   NEW ENGLAND JOURNAL OF MEDICINE

Remdesivir for severe covid-19: a clinical practice guideline

(2020) Bram Rochwerg et al.   BMJ-British Medical Journal

A Randomized, Open‐Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, a Pilot Study

(2020) Zhigang Ren et al.   Advanced Science

Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

(2020) Mayla Gabriela Silva Borba et al.   JAMA Network Open

Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019

(2020) Spyridon G. Deftereos et al.   JAMA Network Open

Interventions for treatment of COVID-19: a protocol for a living systematic review with network meta-analysis including individual patient data (The LIVING Project)

(2020) Sophie Juul et al.   Systematic Reviews

Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial

(2020) Oriol Mitjà et al.   CLINICAL INFECTIOUS DISEASES

RoB 2: a revised tool for assessing risk of bias in randomised trials

(2019) Jonathan A C Sterne et al.   BMJ-British Medical Journal

Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis

(2018) Romina Brignardello-Petersen et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Machine learning for identifying Randomized Controlled Trials: An evaluation and practitioner's guide

(2018) Iain J. Marshall et al.   Research Synthesis Methods

GRADE approach to rate the certainty from a network meta-analysis: Avoiding spurious judgments of imprecision in sparse networks

(2018) Romina Brignardello-Petersen et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

GRADE approach to rate the certainty from a network meta-analysis: addressing incoherence

(2018) Romina Brignardello-Petersen et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

The GRADE Working Group clarifies the construct of certainty of evidence

(2017) Monica Hultcrantz et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Living systematic review: 1. Introduction—the why, what, when, and how

(2017) Julian H. Elliott et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Living cumulative network meta-analysis to reduce waste in research: A paradigmatic shift for systematic reviews?

(2016) Per Olav Vandvik et al.   BMC Medicine

Introduction toBMJRapid Recommendations

(2016) Reed A Siemieniuk et al.   BMJ-British Medical Journal

Introduction toBMJRapid Recommendations

(2016) Reed A Siemieniuk et al.   BMJ-British Medical Journal

The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

(2015) Brian Hutton et al.   ANNALS OF INTERNAL MEDICINE

Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis

(2015) Gert van Valkenhoef et al.   Research Synthesis Methods

Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis

(2014) Rebecca M. Turner et al.   STATISTICS IN MEDICINE

A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis

(2014) M. A. Puhan et al.   BMJ-British Medical Journal

Graphical Tools for Network Meta-Analysis in STATA

(2013) Anna Chaimani et al.   PLoS One

Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods

(2011) Jan O. Friedrich et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)

(2011) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY